Laboratory Director Client Services
Resume:
Report Status: Final
BIRK, LOVEDEEP
Patient Information Specimen Information Client Information
BIRK, LOVEDEEP
DOB: 08/20/1975 AGE: 45
Gender: F Fasting: Y
Phone: 209-***-****
Patient ID: 2594
Health ID: 8573018927776783
Specimen: SZ766818A
Requisition: 0029374
Collected: 02/03/2021 / 07:46 PST
Received: 02/03/2021 / 18:07 PST
Reported: 02/04/2021 / 08:34 PST
Client #: 56009074 MAIL001
HUNDAL, NIRBHAI S
NIRBHAI S. HUNDAL, M.D.
1516 COLORADO AVE
TURLOCK, CA 95380-2711
CLIENT SERVICES: 866-***-**** SPECIMEN: SZ766818A
Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. MRN: 2594
COMMENTS: FASTING:YES
Test Name In Range Out Of Range Reference Range Lab LIPID PANEL WITH REFLEX TO DIRECT LDL
CHOLESTEROL, TOTAL 279 H <200 mg/dL UL
HDL CHOLESTEROL 46 L > OR = 50 mg/dL UL
TRIGLYCERIDES 223 H <150 mg/dL UL
If a non-fasting specimen was collected, consider
repeat triglyceride testing on a fasting specimen
if clinically indicated.
Jacobson et al. J. of Clin. Lipidol. 2015;9:129-169. LDL-CHOLESTEROL 192 H mg/dL (calc) UL
LDL-C levels > or = 190 mg/dL may indicate familial hypercholesterolemia (FH). Clinical assessment and measurement of blood lipid levels should be
considered for all first degree relatives of
patients with an FH diagnosis.
For questions about testing for familial
hypercholesterolemia, please call Quest Genomics
Client Services at 1.866.GENE.INFO.
Jacobson T, et al. J National Lipid Association
Recommendations for Patient-Centered Management of Dyslipidemia: Part 1 Journal of Clinical Lipidology 2015;9(2), 129-169.
Reference range: <100
Desirable range <100 mg/dL for primary prevention;
<70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors.
LDL-C is now calculated using the Martin-Hopkins
calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C.
Martin SS et al. JAMA. 2013;310(19): 2061-2068
(http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO 6.1 H <5.0 (calc) UL
NON HDL CHOLESTEROL 233 H <130 mg/dL (calc) UL
Non-HDL level > or = 220 is very high and may indicate genetic familial hypercholesterolemia (FH). Clinical assessment and measurement of blood lipid levels
should be considered for all first-degree relatives of patients with an FH diagnosis.
For patients with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL
(LDL-C of <70 mg/dL) is considered a therapeutic
option.
COMPREHENSIVE METABOLIC UL
PANEL
PAGE 1 OF 3
Report Status: Final
BIRK, LOVEDEEP
Patient Information Specimen Information Client Information BIRK, LOVEDEEP
DOB: 08/20/1975 AGE: 45
Gender: F Fasting: Y
Patient ID: 2594
Health ID: 8573018927776783
Specimen: SZ766818A
Collected: 02/03/2021 / 07:46 PST
Received: 02/03/2021 / 18:07 PST
Reported: 02/04/2021 / 08:34 PST
Client #: 56009074
HUNDAL, NIRBHAI S
CLIENT SERVICES: 866-***-**** SPECIMEN: SZ766818A
Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. Test Name In Range Out Of Range Reference Range Lab GLUCOSE 167 H 65-99 mg/dL
Fasting reference interval
For someone without known diabetes, a glucose
value >125 mg/dL indicates that they may have
diabetes and this should be confirmed with a
follow-up test.
UREA NITROGEN (BUN) 13 7-25 mg/dL
CREATININE 0.63 0.50-1.10 mg/dL
eGFR NON-AFR. AMERICAN 108 > OR = 60 mL/min/1.73m2 eGFR AFRICAN AMERICAN 126 > OR = 60 mL/min/1.73m2
BUN/CREATININE RATIO NOT APPLICABLE 6-22 (calc)
SODIUM 137 135-146 mmol/L
POTASSIUM 4.5 3.5-5.3 mmol/L
CHLORIDE 101 98-110 mmol/L
CARBON DIOXIDE 27 20-32 mmol/L
CALCIUM 9.1 8.6-10.2 mg/dL
PROTEIN, TOTAL 7.2 6.1-8.1 g/dL
ALBUMIN 4.0 3.6-5.1 g/dL
GLOBULIN 3.2 1.9-3.7 g/dL (calc)
ALBUMIN/GLOBULIN RATIO 1.3 1.0-2.5 (calc)
BILIRUBIN, TOTAL 0.4 0.2-1.2 mg/dL
ALKALINE PHOSPHATASE 73 31-125 U/L
AST 17 10-35 U/L
ALT 38 H 6-29 U/L
HEMOGLOBIN A1C WITH MPG UL
HEMOGLOBIN A1c 8.7 H <5.7 % of total Hgb
For someone without known diabetes, a hemoglobin A1c value of 6.5% or greater indicates that they may have diabetes and this should be confirmed with a follow-up test.
For someone with known diabetes, a value <7% indicates that their diabetes is well controlled and a value greater than or equal to 7% indicates suboptimal
control. A1c targets should be individualized based on duration of diabetes, age, comorbid conditions, and other considerations.
Currently, no consensus exists regarding use of
hemoglobin A1c for diagnosis of diabetes for children. MEAN PLASMA GLUCOSE 232 mg/dL (calc)
TSH W/REFLEX TO FT4 2.24 mIU/L UL
Reference Range
> or = 20 Years 0.40-4.50
Pregnancy Ranges
First trimester 0.26-2.66
Second trimester 0.55-2.73
Third trimester 0.43-2.91
CBC (H/H, RBC, INDICES, UL
WBC, PLT)
PAGE 2 OF 3
Report Status: Final
BIRK, LOVEDEEP
Patient Information Specimen Information Client Information BIRK, LOVEDEEP
DOB: 08/20/1975 AGE: 45
Gender: F Fasting: Y
Patient ID: 2594
Health ID: 8573018927776783
Specimen: SZ766818A
Collected: 02/03/2021 / 07:46 PST
Received: 02/03/2021 / 18:07 PST
Reported: 02/04/2021 / 08:34 PST
Client #: 56009074
HUNDAL, NIRBHAI S
CLIENT SERVICES: 866-***-**** SPECIMEN: SZ766818A
Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. Test Name In Range Out Of Range Reference Range Lab WHITE BLOOD CELL COUNT 8.7 3.8-10.8 Thousand/uL
RED BLOOD CELL COUNT 5.01 3.80-5.10 Million/uL
HEMOGLOBIN 12.9 11.7-15.5 g/dL
HEMATOCRIT 39.9 35.0-45.0 %
MCV 79.6 L 80.0-100.0 fL
MCH 25.7 L 27.0-33.0 pg
MCHC 32.3 32.0-36.0 g/dL
RDW 13.2 11.0-15.0 %
PLATELET COUNT 365 140-400 Thousand/uL
MPV 9.7 7.5-12.5 fL
PERFORMING SITE:
UL QUEST DIAGNOSTICS SACRAMENTO, 3714 NORTHGATE BLVD, SACRAMENTO, CA 95834-1617 Laboratory Director: M. ROSE AKIN, M.D., FCAP, CLIA: 05D0644209 PAGE 3 OF 3
PATIENT/LAB INFORMATION
Requisition No.: 0029374
Collection Date: 2021-02-03
Requisition Status: Final
Patient Name: BIRK, LOVEDEEP
Patient ID: 2594
Patient DOB: 1975-08-20
ANNOTATIONS:
• Created 2021 Feb 04 05:54 PM By HUNDAL, NIRBHAI
To be discussed on follow up
Contact this candidate